Cargando…
Comparison of classical Fabry and its p.D313Y and p.A143T variants by cardiac T1 mapping, LGE and feature tracking myocardial strain
Cardiac manifestation of classical Fabry disease (cFD) varies with sex and presence of left ventricular hypertrophy. p.D313Y/p.A143T variants (vFD) represent milder late-onset phenotypes, however, data on vFD are scarce. Patients with FD (cFD = 37;vFD = 14) and 14 healthy controls underwent 1.5 T CM...
Autores principales: | Avanesov, Maxim, Asgari, Anahid, Muschol, Nicole, Köhn, Anja Friederike, Tahir, Enver, Adam, Gerhard, Kirchhof, Paulus, Lund, Gunnar, Cavus, Ersin, Patten, Monica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086062/ https://www.ncbi.nlm.nih.gov/pubmed/37037838 http://dx.doi.org/10.1038/s41598-023-32464-0 |
Ejemplares similares
-
Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related GLA-Variant p.A143T
por: Godel, Tim, et al.
Publicado: (2020) -
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant
por: Lenders, Malte, et al.
Publicado: (2016) -
Serum Biomarkers of Endothelial Dysfunction in Fabry Associated Cardiomyopathy
por: Loso, Jefferson, et al.
Publicado: (2018) -
CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy
por: Cavus, Ersin, et al.
Publicado: (2021) -
Comparison of global extracellular volume (ECV) and late gadolinium enhancement (LGE) to predict the estimated 5 year risk of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM)
por: Avanesov, Maxim, et al.
Publicado: (2016)